Acute Care Telemedicine Market Size, Share | Report 2022-2030
The global acute care telemedicine market was surpassed at USD 17.62 billion in 2021 and is expected to hit around USD 60.34 billion by 2030, growing at a CAGR of 14.66% from 2022 to 2030.
Report Highlights
Technological development in the healthcare sector, increasing demand for immediate access to medical care, and shortage of specialty physicians especially in developing countries are some factors driving telemedicine growth in an acute care setting.
The COVID-19 pandemic caused the healthcare system to encounter various challenges. The swift adoption of various technologies across countries, driven by the necessity to provide continued medical care in the era of social distancing, has increased the penetration of telemedicine in acute care. In addition, the Centers for Medicare & Medicaid Services (CMS) increased the coverage of telehealth services through temporary waivers soon after the declaration of COVID-19 as a public health emergency in early 2020 to make it convenient for people to receive medical care while reducing their exposure to the virus in public settings such as hospitals and health care facilities.
Furthermore, the World Health Organization and the International Telecommunication Union (ITU) collaborated to produce a universal standard for the usage of telehealth services to address the problem on an international scale. This guideline describes the technological criteria that a telehealth platform must fulfill to deliver accessible telehealth services.
In December 2021, Five Ascension Texas facilities collaborated with the nation’s major multispecialty telemedicine group to offer teleneurology services to their patients. The collaboration was intended to ensure 24/7 access to special neurology care. It will also strengthen on-site neurology treatment by offering doctors, nurses, and other professionals high-definition video consultations with neurologists on demand.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 17.62 billion |
| Revenue Forecast by 2030 | USD 60.34 billion |
| Growth rate from 2022 to 2030 | CAGR of 14.66% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Delivery, application, end-use, region |
| Companies Covered |
ScienceSoft USA Corporation., AMN Healthcare, Orbit Health GmbH, US Acute Care Solutions, LLC., SOC Telemed, SynergenX., Eagle Telemedicine., Vidyo, Inc., RelyMD. |
Delivery Insights
The clinician-to-patient segment accounted for the largest revenue share of 62.52% in 2021. This is owing to the increased adoption of telemedicine solutions by consumers, physicians, and hospitals as patients seek to avoid hospital visits to reduce the chances of exposure to coronavirus. In addition, acute care telemedicine provides access to resources and care for patients in rural areas or areas with a shortage of physicians, improves efficiency and lower medical expense, reduces patient travel, and wait times, and allows for comparable or improved quality of care.
The Clinician-to-clinician segment is expected to witness the fastest CAGR of 15.24% in the forecast period. Clinician-to-clinician acute care telemedicine allows healthcare providers to coordinate with specialists throughout the treatment in emergency cases and real-time patient health monitoring. It provides on-demand access to medical experts in any field to treat abrupt injuries or diseases that can occur in an emergency.
Application Insights
The teleradiology segment dominated the market and held the largest revenue share of 36.57% in 2021. Teleradiology system determined by technological development has emerged as one of the most consistent modes of patient care method in any given situation. The treatment involves various techniques for capturing internal body images such as ultrasound, X-rays, and MRI scans, to help with diagnosis and further treatment plans. Teleradiology also allows healthcare experts to get a medical image from one location and transfer it to another location where it can be explained by a radiologist for diagnostic purposes.
The telepsychiatry segment is estimated to witness the fastest CAGR of 15.51% in the forecast period. This is owing to the increased awareness among people suffering from various mental health conditions such as eating disorders, anxiety, schizophrenia, substance abuse, and several others. The telepsychiatry sector is witnessing significant growth as it holds the potential to become a better option to traditional in-person psychiatric facilities.
End-Use Insights
The hospital and clinics segment dominated the market and held the largest revenue share of 75.54% in 2021 and is expected to continue its dominance in the forecast period. This is owing to the shortage of specialist physicians, especially in developing countries, and increased demand for better healthcare access among the people. Telemedicine solutions are being adopted globally for the triage and treatment of patients, enabling protection for both patients and medical professionals to reduce the risk of exposure.
Virtual options can substantially increase effectiveness compared to in-person physician appointments. Telemedicine also allows the monitoring of patients in emergency cases such as CT assessment of mild traumatic brain injuries. This can assist doctors to decide if the patient needs to admit to a hospital or can be treated locally and allow post-treatment routine checkups. In addition, telehealth provides an at-home interactive audio and video telecommunication system, that allow real-time connection among doctors, nurses, and patients.
Regional Insights
North America dominated the market and accounted for the largest revenue share of 42.44% in 2021. Rapid advancements in the medical sector, allocation of funds for medical research, and developments are some of the key factors contributing to regional market growth. The variety of successful and operational telemedicine and telehealth models and the developed healthcare infrastructure of the region are some of the key factors contributing to the regional market growth. For instance, In March 2020, the U.S. Centers for Medicare & Medicaid Services (CMS) widened access to Medicare telehealth services to provide the beneficiaries with a wider choice of services from their doctors without having to travel to the healthcare facility.
In Europe, the acute care telemedicine market is anticipated to witness rapid growth in the forecast period with a CAGR of 15.28%. The increasing elderly population and the development and deployment of medical technology in European countries are driving the growth of the market in the region. For instance, in September 2022, the health ministers and representatives from WHO, Europe’s 53 member states adopted the region’s first digital health action strategy, an ambitious plan that will influence the digital revolution in central Asia and Europe with the goal of improving people’s health and well-being.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Acute Care Telemedicine Market
5.1. COVID-19 Landscape: Acute Care Telemedicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Acute Care Telemedicine Market, By Delivery
8.1. Acute Care Telemedicine Market, by Delivery, 2022-2030
8.1.1 Clinician-to-patient
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Clinician-to-clinician
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Acute Care Telemedicine Market, By Application
9.1. Acute Care Telemedicine Market, by Application, 2022-2030
9.1.1. Teleradiology
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Telepsychiatry
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. TeleICU
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Teleneurology
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Telenephrology
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Acute Care Telemedicine Market, By End-use
10.1. Acute Care Telemedicine Market, by End-use, 2022-2030
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Others
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Acute Care Telemedicine Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by End-use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Delivery (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 12. Company Profiles
12.1. ScienceSoft USA Corporation.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. AMN Healthcare
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Orbit Health GmbH
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. US Acute Care Solutions, LLC
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. SOC Telemed
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. SynergenX
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Eagle Telemedicine.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Vidyo, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. RelyMD.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers